Dr. Reddy’s gains on launching Sevelamer Carbonate Tablets in US

03 Oct 2017 Evaluate

Dr. Reddy’s Laboratories is currently trading at Rs. 2367.85, up by 38.45 points or 1.65% from its previous closing of Rs. 2329.40 on the BSE.

The scrip opened at Rs. 2406.00 and has touched a high and low of Rs. 2415.00 and Rs. 2355.00 respectively. So far 19,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3394.95 on 28-Oct-2016 and a 52 week low of Rs. 1901.65 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 2477.00 and Rs. 2276.00 respectively. The current market cap of the company is Rs. 39,245.00 crore.

The promoters holding in the company stood at 26.78%, while Institutions and Non-Institutions held 43.38% and 13.68% respectively.

Dr. Reddy’s Laboratories has launched Sevelamer Carbonate Tablets, 800 mg, a therapeutic equivalent generic version of Renvela (sevelamer carbonate) Tablets, approved by the US Food and Drug Administration (USFDA). Dr. Reddy’s Sevelamer Carbonate Tablets, 800 mg are available in the bottle count size of 270 tablets.

The Renvela brand and generic had US sales of approximately $1.88 billion MAT for the most recent twelve months ending in July 2017 according to IMS Health. Renvela is a trademark of Genzyme Corporation.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1246.25 -20.90 (-1.65%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×